One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1200/jco.2015.33.15_suppl.8001
Copy DOI Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2015 |
 Citations: 30 |
Affiliation: Massachusetts General Hospital, Stanford University, City of Hope, The University of Texas MD Anderson Cancer Center, Peter MacCallum Cancer Centre, University of California, Irvine, Clovis Oncology (United States), University of Colorado Cancer Center, Memorial Sloan Kettering Cancer Center, Virginia Cancer Specialists, The Ohio State University, Georgetown University, Institut Gustave Roussy, Dana-Farber Cancer Institute8001 Background: Rociletinib is an oral inhibitor of mutant EGFR, including the T790M resistance mutation. We reported robust activity in T790M positive pts identified by tumor genotyping treated a...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
